A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Panelists discuss how transitioning patients from intravenous (IV) to subcutaneous (SubQ) therapies demands a coordinated, multidisciplinary approach—integrating clinical judgment, electronic medical ...

BMS beats MSD to the US subcutaneous PD-1 inhibitor market after Opdivo Qvantiq is cleared across nearly all the indications of the IV form.

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

Botox is sometimes used to relax the muscles in your face to reduce the appearance of smile lines. We'll discuss the details.